Market closed · Oct 6, 4:20 am ET · Last extended-hours $32.59 0.00%
Open$31.83
Prev close$31.65
Day range$31.50 – $32.88
Volume1.26M
Market cap$2.56B
P/E (TTM)–
Dividend yield–
CLDX Stock News
Headlines matching Celldex Therapeutics or the CLDX ticker, most recent first.
LifeSci Capital Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $64Market news · 28 Sep 2026
Morgan Stanley Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $57Market news · 24 Sep 2026
A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $50 to $88Market news · 24 Sep 2026
A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $50 to $100Market news · 23 Sep 2026
LifeSci Capital Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $56Market news · 21 Sep 2026
Morgan Stanley Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $50Market news · 10 Sep 2026
A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $42 to $56Market news · 8 Aug 2026
A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $42 to $100Market news · 7 Aug 2026
Wells Fargo Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $72Market news · 29 Jul 2026
A Quick Look at Today's Ratings for Celldex Therapeutics(CLDX.US), With a Forecast Between $40 to $70Market news · 23 Jul 2026
Analysts Are Bullish on These Healthcare Stocks: Celldex (CLDX), Belite Bio, Inc. ADR (BLTE)TipRanks · 22 Jul 2026
Guggenheim Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Raises Target Price to $100Market news · 20 Jul 2026
Wells Fargo Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $54Market news · 30 Jun 2026
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION), Celldex (CLDX) and Jazz Pharmaceuticals (JAZZ)TipRanks · 18 Jun 2026
Cantor Fitzgerald Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $67Market news · 15 Jun 2026
Discussion
No comments yet — be the first to weigh in on CLDX.
No comments yet — be the first to weigh in on CLDX.